BR112022016508A2 - Intermediário de trolox opticamente resolvido e método para produção do mesmo - Google Patents

Intermediário de trolox opticamente resolvido e método para produção do mesmo

Info

Publication number
BR112022016508A2
BR112022016508A2 BR112022016508A BR112022016508A BR112022016508A2 BR 112022016508 A2 BR112022016508 A2 BR 112022016508A2 BR 112022016508 A BR112022016508 A BR 112022016508A BR 112022016508 A BR112022016508 A BR 112022016508A BR 112022016508 A2 BR112022016508 A2 BR 112022016508A2
Authority
BR
Brazil
Prior art keywords
trolox
formula
production
compound
optically resolved
Prior art date
Application number
BR112022016508A
Other languages
English (en)
Portuguese (pt)
Inventor
Kuroda Kiichi
Sawamura Kiyoto
Tsuyumine Shinjiro
Original Assignee
Sumitomo Pharma Co Ltd
Ptc Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Pharma Co Ltd, Ptc Therapeutics Inc filed Critical Sumitomo Pharma Co Ltd
Publication of BR112022016508A2 publication Critical patent/BR112022016508A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • A61K31/122Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/66Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/27Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring having amino groups linked to the six-membered aromatic ring by saturated carbon chains
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/12Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/30Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being unsaturated and containing rings other than six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR112022016508A 2020-02-21 2021-02-19 Intermediário de trolox opticamente resolvido e método para produção do mesmo BR112022016508A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020028614 2020-02-21
PCT/JP2021/006465 WO2021167095A1 (ja) 2020-02-21 2021-02-19 光学分割されたトロロックス中間体およびその製造方法

Publications (1)

Publication Number Publication Date
BR112022016508A2 true BR112022016508A2 (pt) 2022-10-11

Family

ID=77390820

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022016508A BR112022016508A2 (pt) 2020-02-21 2021-02-19 Intermediário de trolox opticamente resolvido e método para produção do mesmo

Country Status (8)

Country Link
US (1) US12509434B2 (https=)
EP (1) EP4108658A4 (https=)
JP (2) JP7840259B2 (https=)
KR (1) KR20220143897A (https=)
CN (1) CN115066420B (https=)
BR (1) BR112022016508A2 (https=)
IL (1) IL295785A (https=)
WO (1) WO2021167095A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CR20250133A (es) 2022-09-12 2025-06-26 Ptc Therapeutics Inc Granulos para suspension
AU2023352262A1 (en) 2022-09-30 2025-04-24 Ptc Therapeutics, Inc. Oxidative cleavage method of trolox amide
WO2025117870A1 (en) 2023-12-01 2025-06-05 Ptc Therapeutics, Inc. Method of electrolytic oxidative cleavage of trolox amide
WO2025193975A1 (en) 2024-03-13 2025-09-18 Ptc Therapeutics, Inc. Formulations for stabilizing dissolution of medicaments

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA739471B (en) * 1972-12-22 1974-08-28 Hoffmann La Roche Chromane derivatives
US3947473A (en) 1972-12-22 1976-03-30 Hoffman-La Roche Inc. Antioxidant chroman compounds
US4003919A (en) 1973-11-19 1977-01-18 Hoffmann-La Roche Inc. Antioxidant chroman compounds
US4026907A (en) 1973-11-19 1977-05-31 Hoffmann-La Roche Inc. Antioxidant chroman compounds
WO2002012221A1 (en) * 2000-08-03 2002-02-14 Kuraray Co., Ltd. Method for optical resolution of (±)-6-hydroxy-2,5,7,8-tetramethylcoumarone-2-carboxylic acid
JP2002167381A (ja) * 2000-08-03 2002-06-11 Kuraray Co Ltd (±)−6−ヒドロキシ−2,5,7,8−テトラメチルクロマン−2−カルボン酸の光学分割法
EA038941B1 (ru) 2007-11-06 2021-11-12 ПиТиСи ТЕРАПЬЮТИКС, ИНК. ПРОИЗВОДНЫЕ 4-(п-ХИНОНИЛ)-2-ГИДРОКСИБУТАНАМИДА ДЛЯ ЛЕЧЕНИЯ МИТОХОНДРИАЛЬНЫХ ЗАБОЛЕВАНИЙ
JP5598330B2 (ja) * 2008-10-29 2014-10-01 三菱瓦斯化学株式会社 光学活性有機カルボン酸の製造方法
KR20110086723A (ko) 2008-11-07 2011-07-29 시플라 리미티드 조피클론을 광학분할하는 방법
JP5641802B2 (ja) * 2010-07-26 2014-12-17 株式会社トクヤマ (s)−4−〔(4−クロロフェニル)(2−ピリジル)メトキシ〕ピペリジンのジアステレオマー塩の製造方法
JPWO2013011999A1 (ja) * 2011-07-20 2015-02-23 株式会社カネカ 光学活性2−メチルプロリン誘導体の製造法
CN105164105B (zh) 2013-04-10 2018-01-30 第一三共株式会社 吡咯衍生物的结晶及其制备方法
DK3233786T3 (da) * 2014-12-16 2022-05-09 Ptc Therapeutics Inc Polymorfe og amorfe former af (r)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6- dioxocyclohexa-1,4-dienyl)butanamid
EP3233819A1 (en) * 2014-12-16 2017-10-25 Bioelectron Technology Corporation Methods for chiral resolution of trolox
JP2020028614A (ja) 2018-08-24 2020-02-27 株式会社三共 遊技機

Also Published As

Publication number Publication date
IL295785A (en) 2022-10-01
US12509434B2 (en) 2025-12-30
JPWO2021167095A1 (https=) 2021-08-26
JP2026041900A (ja) 2026-03-10
EP4108658A4 (en) 2024-05-22
JP7840259B2 (ja) 2026-04-03
WO2021167095A1 (ja) 2021-08-26
CN115066420A (zh) 2022-09-16
EP4108658A1 (en) 2022-12-28
CN115066420B (zh) 2024-12-10
KR20220143897A (ko) 2022-10-25
US20230029044A1 (en) 2023-01-26

Similar Documents

Publication Publication Date Title
BR112022016508A2 (pt) Intermediário de trolox opticamente resolvido e método para produção do mesmo
ES8202777A1 (es) Un procedimiento para la preparacion de fenoxialcoxifenil derivados
ES8106721A1 (es) Un metodo para la preparacion de derivados de ftalimidina
FR3030240B1 (fr) Procede de traitement des fibres keratiniques avec une composition comprenant un acide amine
MX2020003815A (es) Sintesis de cantaridina.
ES2060721T3 (es) Composiciones de reactivos a base de fosfonatos y metodos para fabricar las mismas.
BR112023011805A2 (pt) Processo para produzir um composto
BR0012915A (pt) Processo para obter nitroxialquilésteres do ácido 2-(s)-(g-metoxi-2-naftil)-propanóico
PT92180A (pt) Processo para a preparacao de novas mevalonolactonas do tipo tienopiridina e de composicoes farmaceuticas que as contem
BR7907226A (pt) Processo para producao de eter por reacao de pelo menos uma olefina que apresenta uma dupla ligacao sobre um atomo de carbono terciario com pelo menos um alcool
Chun et al. A concise route to d-erythro-sphingosine from N-Boc-l-serine derivatives via sulfoxide or sulfone intermediates
CL2023002359A1 (es) Métodos de preparación de glufosinato.
ES2032582T3 (es) Procedimiento para preparar derivados de la oxima del 1,2,5,6,-tetrahidropiridin -3-carboxialdehido.
PT80791B (pt) Processo para a preparacao de novas fenil-naftiridinas uteis nomeadamente como medicamentos anti-ulcerosos
BR0112528A (pt) Processo para a produção de compostos, processo para a preparação de um enantiÈmero de um composto, enantiÈmero, composição inseticida, acaricida e nematicida, e, método de combate e controle de pestes de acarinos ou nematóides
Misra et al. Dimethylchrysenediol epoxides: mutagenicity in Salmonella typhimurium, tumorigenicity in newborn mice, and reactivity with deoxyadenosine in DNA
ES8105692A1 (es) Un procedimiento para preparar acidos 2-nitrobenzoicos sus- tituidos con fenoxi en la posicion 5
SG11201908102TA (en) Novel compound, fluorescence derivatization reagent including said novel compound, method for optically resolving optical isomer of amino acid in which said novel compound is used, and fluorescence derivatized amino acid
MX2023015490A (es) Inhibidores de las transglutaminasas.
ES8105993A1 (es) Un procedimiento para la preparacion de fenil-quinolicidinas
Suga et al. α-Fluoro-and α, α-difluoroalkanals by substitution of vicinal bromofluoroalkanes and subsequent pummerer rearrangement
ES8607922A1 (es) Procedimiento para preparar 9-oxo-15 a-hidroxi-16-fenoxi y 16-fenoxi sustituido-17,18,19,20-tetranorprosta-4,5,13 (e)- trienoatos
BR112023019534A2 (pt) Processo químico
ES8105741A1 (es) Un procedimiento para preparar compuestos de tiofosfonato nosimetricos
ES455532A1 (es) Procedimiento para la preparacion de triazapentadienos.

Legal Events

Date Code Title Description
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B25G Requested change of headquarter approved

Owner name: PTC THERAPEUTICS, INC. (US) ; SUMITOMO PHARMA CO., LTD. (JP)

B25A Requested transfer of rights approved

Owner name: PTC THERAPEUTICS, INC. (US)

B154 Notification of filing of divisional application [chapter 15.50 patent gazette]

Free format text: O PEDIDO FOI DIVIDIDO NO BR122025015739-2 PROTOCOLO 870250065617 EM 29/07/2025 15:05.